The worse survival of early-onset cases has been attributed to a higher incidence of adverse pathological features (higher histological grade14, more frequent ER- and progesterone receptor (PR)-negative tumours)15,16 but multivariable analysis has demonstrated that age is an independent risk factor after adjusting for stage, treatment and tumour characteristics12. This evidence concerns the gene ESR1 and neoplasm.